Immune Recovery Uveitis in a CMV Retinitis Patient Without Hiv Infection

Bessho, Kenichiro; Schrier, Rachel; Freeman, William R.

doi:10.1097/01.icb.0000256952.24403.42

Cited by 4 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our review identified a total of 248 eyes of 178 patients previously reported with CMVR in the absence of either HIV infection, Good syndrome, or prior periocular or intraocular corticosteroid injection (Additional file 1 : Table S1) [ 17 – 86 ]. Reported ages ranged from 1 week to 84 years, with a mean and median of 45.7 and 48.0 years, respectively.…”

Section: Reviewmentioning

confidence: 99%

“…Of the 248 eyes of 178 patients with CMVR in the absence of either HIV infection or Good syndrome that have been described in the literature (Additional file 1 : Table S1), 16 eyes (6.5 %) of 10 patients had one or more features consistent with IRU [ 17 , 20 , 45 , 50 , 70 ]. Reported ages of these 10 patients ranged from 15 to 68 years, with a mean and median of 47.8 and 54 years, respectively.…”

Section: Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients—case report and comprehensive review of the literature

Downes

Tarasewicz

Weisberg

et al. 2016

J Ophthal Inflamm Infect

View full text Add to dashboard Cite

We describe a 65-year-old Thai woman who developed cytomegalovirus retinitis (CMVR) in the setting of Good syndrome—a rare, acquired partial immune deficiency caused by thymoma. The patient subsequently developed vitritis with cystoid macular edema (CME) similar to immune recovery uveitis (IRU) despite control of the retinitis with antiviral agents. A comprehensive review of the literature through December, 2014, identified an additional 279 eyes of 208 patients with CMVR in the absence of human immunodeficiency virus (HIV) infection. Including our newly reported case, 9 of the 208 patients (4.3 %) had Good syndrome. Twenty-one of the 208 patients (10.1 %) had CMVR related to intraocular or periocular corticosteroid administration. The remaining 178 patients (85.6 %) acquired CMVR from other causes. Within the subset of patients who did not have Good syndrome or did not acquire CMVR followed by intraocular or periocular corticosteroid administration, there were many other factors contributing to a decline in immune function. The most common included age over 60 years (33.1 %), an underlying malignancy (28.7 %), a systemic autoimmune disorder requiring systemic immunosuppression (19.1 %), organ (15.2 %) or bone marrow (16.3 %) transplantation requiring systemic immunosuppression, and diabetes mellitus (6.1 %). Only 4.5 % of the patients had no identifiable contributor to a decline in immune function. While the clinical features of CMVR are generally similar in HIV-negative and HIV-positive patients, the rates of moderate to severe intraocular inflammation and of occlusive retinal vasculitis appear to be higher in HIV-negative patients.Electronic supplementary materialThe online version of this article (doi:10.1186/s12348-016-0070-7) contains supplementary material, which is available to authorized users.

show abstract

Section: Reviewmentioning

confidence: 99%

Section: Reviewmentioning

confidence: 99%

Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients—case report and comprehensive review of the literature

Downes

Tarasewicz

Weisberg

et al. 2016

J Ophthal Inflamm Infect

View full text Add to dashboard Cite

show abstract

Immune recovery uveitis: a focus review

Rodrigues Alves,

Barão,

Mota

et al. 2024

Graefes Arch Clin Exp Ophthalmol

View full text Add to dashboard Cite

Immune recovery uveitis (IRU) is an intraocular inflammation that typically occurs as part of immune reconstitution inflammatory syndrome (IRIS) in the eye. Typically, it affects human immunodeficiency virus (HIV)-infected patients with recognized or unrecognized cytomegalovirus (CMV) retinitis who are receiving highly active antiretroviral therapy (HAART). IRU is a common cause of new vision loss in these patients, and it manifests with a wide range of symptoms and an increased risk of inflammatory complications, such as macular edema. Recently, similar IRU-like responses have been observed in non-HIV individuals with immune reconstitution following immunosuppression of diverse etiologies, posing challenges in diagnosis and treatment. This review provides an updated overview of the current literature on the epidemiology, pathophysiology, biomarkers, clinical manifestations, diagnosis, differential diagnosis, and treatment strategies for IRU.

show abstract

Respuesta similar a la uveítis de recuperación inmune en un paciente con retinitis herpética como complicación de una leucemia de células peludas

Sánchez-Vicente

Rueda-Rueda

Moruno-Rodríguez

et al. 2019

Archivos de la Sociedad Española de Oftalmología

View full text Add to dashboard Cite

Immune Recovery Uveitis in a CMV Retinitis Patient Without Hiv Infection

Abstract: Immune recovery uveitis can occur in immune reconstituted HIV-negative patients with cytomegalovirus retinitis.

Cited by 4 publications

References 5 publications

Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients—case report and comprehensive review of the literature

Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients—case report and comprehensive review of the literature

Immune recovery uveitis: a focus review

Respuesta similar a la uveítis de recuperación inmune en un paciente con retinitis herpética como complicación de una leucemia de células peludas

Contact Info

Product

Resources

About